Back to Trades
Other4
GILEAD SCIENCES, INC.
GILD
Total Value
$4.8M
Company Information
- Company Name
- GILEAD SCIENCES, INC.
- Ticker Symbol
- GILD
- CIK
- 0000882095
Insider Information
- Name
- Berger Dietmar
- Role
- Chief Medical Officer
- Location
- FOSTER CITY, CA
Officer
Filing Details
- Filing Date
- Mar 12, 2026
- Transaction Date
- Mar 10, 2026
- Accession Number
- 0001739515-26-000006
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Common Stock | 2,133 | — | Exercise | — |
| Mar 10, 2026 | Common Stock | 1,063 | $148.56 | Tax Withholding | $157.9K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Derivative | 2,133 | — | Exercise | — |
| Mar 10, 2026 | Derivative | 8,415 | — | Grant/Award | — |
| Mar 10, 2026 | Derivative | 31,475 | $148.56 | Grant/Award | $4.7M |
Footnotes
- (F1)Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- (F2)The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
- (F3)The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.